Evaluation of a vaccination strategy by serosurveillance data: The case of varicella

References

• Gay NJ, Morgan-Capner P, Wright J, Farrington CP, Miller E. Age-specific antibody prevalence to hepatitis A in England: implications for disease control. Epidemiol Infect 1994; 113:113-20; PMID:8062867; http://dx.doi.org/10.1017/S0950268800051529
   PubMed Web of Science ®Google Scholar
• Gay NJ, Hesketh LM, Morgan-Capner P, Miller E. Interpretation of serological surveillance data for measles using mathematical models: implications for vaccine strategy. Epidemiol Infect 1995; 115:139-56; PMID:7641827; http://dx.doi.org/10.1017/S0950268800058209
   PubMedGoogle Scholar
• Morris-Cunnington MC, Edmunds WJ, Miller E, Brown DW. A population-based seroprevalence study of hepatitis A virus using oral fluid in England and Wales. Am J Epidemiol 2004 Apr 15; 159(8):786-94; http://dx.doi.org/10.1093/aje/kwh107
   PubMed Web of Science ®Google Scholar
• Paul JR. Knowledge and trends in poliomyelitis: a summary. poliomyelitis: papers and discussions presented at the second international poliomyelitis conference. JB Lippencott; Philadelphia, 1951.
   Google Scholar
• Gear JHS. Distribution of antibodies to poliomyelitis virus in the general population. poliomyelitis: papers and discussions presented at the third international poliomyelitis conference. JB Lippencott; Philadelphia, 1954.
   Google Scholar
• Halsey NA. The optimal age for administering measles vaccine in developing countries. In: Halsey NA. & de Quadros C., ed. Recent advances in immunization, a bibliographic review (Scientific Publication No. 451), Washington, Pan American Health Organization, 1983, 4-17.
   Google Scholar
• La Torre G, de Waure C, Chiaradia G, Mannocci A, Capri S, Bamfi F, Ricciardi W. Guidance for future HTA applications to vaccines: the HPV lesson. Hum Vaccin 2011 Sep; 7(9):900-4; http://dx.doi.org/10.4161/hv.7.9.16084
   PubMed Web of Science ®Google Scholar
• Marks JS, Hayden GF, Orenstein WA. Methodologic issues in the evaluation of vaccine effectiveness: measles vaccine at 12 vs. 15 months. Am J Epidemiol 1982 Sep; 116(3):510-23.
   PubMed Web of Science ®Google Scholar
• Ukkonen P. Rubella immunity and morbidity: impact of different vaccination programs in Finland 1979–1992. Scand J Infect Dis 1996; 28:31-35; PMID:9122630; http://dx.doi.org/10.3109/00365549609027146
   PubMed Web of Science ®Google Scholar
• Tafuri S, Prato R, Martinelli D, Calvario A, Bozzi A, Labianca M, Patti A, Lopalco PL, Germinario C. Serological survey on immunity status against polioviruses in children and adolescents living in a border region, Apulia (Southern Italy). BMC Infect Dis 2008 Oct 30; 8:150; http://dx.doi.org/10.1186/1471-2334-8-150
   PubMed Web of Science ®Google Scholar
• Anderson RM, May RM. Age-related changes in the rate of disease transmission: implications for the design of vaccination programmes. J Hyg Camb 1985;94:365-435; PMID:4008922; http://dx.doi.org/10.1017/S002217240006160X
   PubMedGoogle Scholar
• Anderson RM, Grenfell BT. Quantitative investigations of different rubella vaccination policies for the control of congenital rubella syndrome (CRS) in the United Kingdom. J Hyg Camb 1986; 96:305-33; PMID:3701044; http://dx.doi.org/10.1017/S0022172400066079
   PubMedGoogle Scholar
• Germinario C, Chironna M, Quarto M, Lopalco P, Calvario A, Barbuti S. Immunosurveillance on Kosovar children refugees in Southern Italy. Vaccine 2000 Apr 14; 18(20):2073-4; http://dx.doi.org/10.1016/S0264-410X(99)00557-5
   PubMed Web of Science ®Google Scholar
• CDC. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention. MMWR Recomm Rep 1996 Jul 12; 45(RR-11):1-36.
   Google Scholar
• Varicella vaccines. WHO position paper. Wkly Epidemiol Rec 1998; 73(32):241-8; PMID:9715106
   PubMedGoogle Scholar
• CDC. Prevention of varicella: updated recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1999 May 28; 48(RR-6):1-5.
   Google Scholar
• Marin M, Güris D, Chaves SS, Schmid S, Seward JF. Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention (CDC). Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007 Jun 22; 56(RR-4):1-40.
   PubMedGoogle Scholar
• Flatt A, Breuer J. Varicella vaccines. Br Med Bull 2012; 103:115-12; http://dx.doi.org/10.1093/bmb/lds019
   PubMed Web of Science ®Google Scholar
• Streng A, Grote V, Carr D, Hagemann C, Liese JG. Varicella routine vaccination and the effects on varicella epidemiology – results from the Bavarian Varicella Surveillance Project (BaVariPro), 2006-2011. BMC Infec Dis 2013; 13:303; PMID:23815523; http://dx.doi.org/10.1186/1471-2334-13-303
   PubMed Web of Science ®Google Scholar
• VENICE. Varicella and herpes zoster surveillance and vaccination recommendations. 2011. Available from: http://venice.cineca.org/report_final_varicella.pdf.
   Google Scholar
• European Centre for Disease Prevention and Control. Varicella vaccine in the European Union. Stockholm: ECDC; 2014.
   Google Scholar
• Reynolds MA, Kruszon-Moran D, Jumaan A, Schmid DS, McQuillan GM, Varicella Seroprevalence in the U.S.: Data from the National Health and Nutrition Examination Survey, 1999–2004. Public Health Rep November–December 2010; 125:860:869.
   Google Scholar
• Gidding HF, MacIntyre CR, Burgess MA, Gilbert GL. The seroepidemiology and transmission dynamics of varicella in Australia. Epidemiol Infect 2003; 131:1085-9; PMID:14959774; http://dx.doi.org/10.1017/S0950268803001134
   PubMed Web of Science ®Google Scholar
• Macartney KK, Burgess MA. Varicella Vaccination in Australia and New Zealand. J Infect Dis 2008 Mar 1; 197 Suppl 2:S191-5.
   PubMed Web of Science ®Google Scholar
• Nardone A, de Ory F, Carton M, Cohen D, van Damme P, Davidkin I, Rota MC, de Melker H, Mossong J, Slacikova M, et al. The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region. Vaccine 2007 Nov 7; 25(45):7866-72; http://dx.doi.org/10.1016/j.vaccine.2007.07.036
   PubMed Web of Science ®Google Scholar
• D'Ancona F, Alfonsi V, Ciofi degli Atti ML. [Survey on vaccination strategies used in different Italian Regions, for the 7-valent conjugate pneumococcal, meningococcal C and varicella vaccines]. Ig Sanita Pubbl 2006 Sep-Oct; 62(5):483-92.
   PubMedGoogle Scholar
• Ueno-Yamamoto K, Tanaka-Taya K, Satoh H, Araki K, Kaku M, Okabe N. The changing seroepidemiology of varicella in Japan: 1977-1981 and 2001-2005. Pediatr Infect Dis J 2010 Jul; 29(7):667-9; http://dx.doi.org/10.1097/INF.0b013e3181d732fe
   PubMed Web of Science ®Google Scholar
• Tafuri S, Gallone MS, Cappelli MG, Gallone MF, Larocca AM, Germinario C. A seroprevalence survey on varicella among adults in the vaccination era in Apulia (Italy). Vaccine 2014 Nov 12; 32(48):6544-7; http://dx.doi.org/10.1016/j.vaccine.2014.08.088
   PubMed Web of Science ®Google Scholar
• van Hoek AJ, Melegaro A, Zagheni E, Edmunds WJ, Gay N. Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England. Vaccine 2011 Mar 16; 29(13):2411-20; http://dx.doi.org/10.1016/j.vaccine.2011.01.037
   PubMed Web of Science ®Google Scholar
• Brisson M, Melkonyan G, Drolet M, De Serres G, Thibeault R, De Wals P. Modeling the impact of one- and two-dose varicella vaccination on the epidemiology of varicella and zoster. Vaccine 2010 Apr 26; 28(19):3385-97; http://dx.doi.org/10.1016/j.vaccine.2010.02.079
   PubMed Web of Science ®Google Scholar